Results 231 to 240 of about 27,163 (253)

Fingolimod

Reactions Weekly, 2014
openaire   +1 more source

Fingolimod

Reactions Weekly, 2023
openaire   +1 more source

Fingolimod

Reactions Weekly, 2010
openaire   +1 more source

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial

Lancet, The, 2016
Fred Lublin, Mark S Freedman, Jerry S Wolinsky   +2 more
exaly  

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

New England Journal of Medicine, 2010
Ludwig Kappos, Krzysztof Selmaj
exaly  

Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis

Clinical Neuropharmacology, 2010
Jerold Chun
exaly  

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Lancet Neurology, The, 2017
Tomas Kalincik, J William L Brown, Neil P Robertson   +2 more
exaly  

Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

Annals of Neurology, 2020
Peter Alping, Johan Askling, Joachim Burman   +2 more
exaly  

Impact of an immune modulator fingolimod on acute ischemic stroke

Proceedings of the National Academy of Sciences of the United States of America, 2014
Ying Fu, Li Ren, Qiang Liu
exaly  

Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis

Annals of Neurology, 2011
Jeffrey A Cohen, Jerold Chun
exaly